TD Cowen Reiterates Buy Rating and Top Pick on Roivant Sciences (ROIV) Mar 4, 2026 08:36AM
TD Cowen on Roivant Sciences (ROIV): 'We are overall very encouraged by this given importance of the molar ratio patents to ABUS' case' Sep 10, 2025 01:44PM
TD Cowen on Roivant Sciences (ROIV): 'We Like the Risk/Reward Profile of the Stock' Sep 2, 2025 09:28AM
TD Cowen Reiterates Buy Rating on Roivant Sciences (ROIV) Sep 18, 2024 11:56AM
TD Cowen Reiterates Buy Rating on Roivant Sciences (ROIV) Sep 11, 2024 08:59AM


Feb 3, 2023 05:54AM Roivant Sciences (ROIV) Prices Upsized 26.67M Share Offering at $7.50/sh
Feb 2, 2023 09:14PM Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares
Feb 2, 2023 09:14PM Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares
Feb 1, 2023 04:05PM Roivant Sciences (ROIV) Announces Proposed $150M Share Offering
Feb 1, 2023 04:05PM Roivant Sciences Announces Proposed Public Offering of Common Shares
Feb 1, 2023 04:05PM Roivant Sciences Announces Proposed Public Offering of Common Shares
Jan 30, 2023 08:00AM Roivant to Report Financial Results for the Third Quarter Ended December 31, 2022 on Monday, February 13, 2023
Jan 30, 2023 08:00AM Roivant to Report Financial Results for the Third Quarter Ended December 31, 2022 on Monday, February 13, 2023
Feb 7, 2022 07:00AM Roivant to Report Financial Results for the Quarter Ended December 31, 2021 on Monday, February 14, 2022
Feb 7, 2022 07:00AM Roivant to Report Financial Results for the Quarter Ended December 31, 2021 on Monday, February 14, 2022
Oct 26, 2021 08:47AM Roivant Sciences (ROIV) Stock Surges 20% as Three Street Firms Initiate Coverage With Positive Ratings
Oct 26, 2021 05:38AM Cowen Starts Roivant Sciences (ROIV) at Outperform
Oct 1, 2021 08:00AM Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing
May 3, 2021 07:01AM Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology